Boston Scientific downgraded by Analyst with a new price target
Stocks in this Quantisnow insightHealth Care
Historical context for BSX
Across the 22 sessions after earlier BSX headlines, the stock closed higher 9 times and lower 13 times, with a median move of 1.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | BSX | SPY |
|---|---|---|---|
| Oct 26, 2026 | Boston Scientific to participate in Stifel's 2026 Healthcare Conference | -0.2% | +0.7% |
| Oct 7, 2026 | Barclays initiated coverage on Boston Scientific with a new price targetand 1 other headline that session | -1.4% | -0.2% |
| Sep 17, 2026 | Boston Scientific downgraded by Citigroup with a new price target | -0.8% | +1.1% |
| Aug 10, 2026 | Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results | +2.3% | -0.0% |
| Jul 31, 2026 | Boston Scientific downgraded by Argus | +1.6% | +0.7% |
| Jul 29, 2026 | Boston Scientific announces results for second quarter 2026 | -0.0% | -1.5% |
Quantisnow market dataNYSE
BSX
Boston Scientific Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Get push alerts for BSX
Full BSX profile on Quantisnow Follow BSX and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time